Search results for: 'spend'

This growth insight is part of an ongoing quarterly tracker that monitors the trends and the developments in the Singapore automotive market. The study employs multi-level secondary and primary sources for data collation, including country-level official associations/federations, government authorities, country subject experts, and third-party sour...

Frost & Sullivan’s analysis of the oral solid dosage excipients market aims at quantifying the consumption and analyzing the impact of key disruptive, transformative, and competitive trends across the value chain order to present a forecast for the eight year period of 2022 to 2030. The scope of the study comprises analysis of the oral solid dosage...

11 Sep 2018  |  Global  |  Market Research

Strategic Analysis of the Renault-Nissan-Mitsubishi Alliance

By Launching 12 New EV Models, the Alliance is Set to be the First to Cross the One-million-a-year Sales Mark by 2022

Infographics

×

In 2017, the Renault-Nissan-Mitsubishi Alliance sold an estimated 10.6 million passenger vehicles and light commercial vehicles (LCVs), making it the best-selling automotive group in the world. Such an achievement stems from the Alliances commitment to driving maximum synergies, while enabling individual brands to retain their distinct identitie...

In this report, Frost & Sullivan studies the above-the-neck PPE market in North America, covering products that users wear for protection against hazards that can cause injuries to the head, eyes, face, and ears. This research analyzes technology trends, industry challenges and drivers, and the current status and prospects in the region, including ...

In H2 2022, the APAC network firewall market witnessed a slightly slower YoY growth of 11.0% in comparison to the YoY growth of approximately 13.0% in H1 2022. This slower growth reflects the cautious spending sentiment amidst the changing macro environment in 2022 as customers demand for more value for their cybersecurity investments. This changin...

Despite a subdued economic outlook, 2023 is forecast to remain upbeat for the global healthcare industry, supported by steady emerging market growth, increased post-pandemic health-centric policies, rapidly aging populations in major developed nations, and higher R&D spending. Rapid technological advancements and digital transformation are improvin...

Our society's approach to producing, consuming, and distributing energy is changing due to mounting concerns about global warming and rising CO2 levels in the atmosphere. Governments worldwide are formulating regulatory frameworks, increasing their investments in low-carbon technologies to slow climate change, and decarbonizing their economies. An ...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...